The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and Indonesia
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered
New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination
Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictions
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.